New anticancer treatment technology targets cancer cell lysosomes and overcomes drug resistance

A groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance has been developed by Professor Ja-Hyoung Ryu and his research team in the Department of Chemistry at UNIST.

Related Keywords

United States ,South Korea ,American ,Korea ,Ja Hyoung Ryu ,Megan Craig ,Department Of Chemical ,National Research Foundation Of Korea ,Technology Development Program ,Research Professor Batakrishna Jana Department Of Chemistry ,Engineering At Korea University ,Department Of Chemistry ,Ministry Of Science ,Journal Of The American Chemical Society ,Seongeon Jin Korea Institute Of Science ,Professor Ja Hyoung Ryu ,Research Professor Batakrishna Jana ,Seongeon Jin ,Korea Institute ,Professor Sang Kyu Kwak ,Biological Engineering ,Korea University ,Mid Career Researcher Project ,Medical Technology Development Program ,National Research Foundation ,American Chemical Society ,Cancer ,Fell ,Drugs ,Lysosomes ,Research ,Technology ,